ChinaDaily Briefs

Daily Brief China: Guangdong Investment, Tencent, Magic Empire Global, Zhangzhou Pientzehuang Pharmaceutical Co., Ltd., Sino-Ocean Group and more

In today’s briefing:

  • S&P Global Water Index: Market Consultation Driven Potential Changes
  • Tencent New Lows in Sight
  • Magic Empire Global – Not Clear Who Is Driving and Who Is Being Taken For a Ride
  • Tencent Looking to Raise Its Stake in Ubisoft at a Huge Premium
  • Zhangzhou Pientzehuang Pharmaceutical (600436CH) 22H1- 2022 Is Stressful but Shares Will Bounce Back
  • Morning Views Asia: China SCE, KWG Living Group, Longfor Properties, Sino-Ocean Service

S&P Global Water Index: Market Consultation Driven Potential Changes

By Brian Freitas

  • S&P DJI commenced a market consultation for the S&P Global Water Index on 29 July and that could lead to quite a few changes to the index in October.
  • We currently see 14 deletions and 10 inclusions for the index in October. Most of the changes will have a high impact from passive fund trading.
  • There could be more changes in April 2023 once stocks listed in Emerging Markets are included in the index.

Tencent New Lows in Sight

By Thomas Schroeder

  • Tencent short from 390 is rewarding and reaching for new chart lows now that the 310 pivot support has given way and leading the likes of BABA.
  • MACD target support is the key input to align with a terminal wave 5 low to set up the macro long entry in September.
  • Undershoot risk to lower channel support with a low due in September and rally hurdles toward year end at 370/390. 420 remains the forward macro barrier to challenge/clear.

Magic Empire Global – Not Clear Who Is Driving and Who Is Being Taken For a Ride

By Travis Lundy

  • Just days after AMTD Digital (HKD US) was ramped 30,000% to a ridiculous valuation only weeks after its IPO, Magic Empire Global (MEGL US) IPOed and rose 2000+ on Day1.
  • MEGL is a corporate advisory, helping smallcaps IPO then helping them comply with listing rules. 2 principals, 2 professionals, 5 staff with no moat had US$2.16mm in revenue in 2021.
  • And it is worth US$2.3bn – 1000 x revenues and 10,000x earnings?  This is not OK. And it smacks of something unsavoury. 

Tencent Looking to Raise Its Stake in Ubisoft at a Huge Premium

By Shifara Samsudeen, ACMA, CGMA

  • Reuters and several other news media outlets reported that Tencent (700 HK) is looking to raise its stake in French game publisher Ubisoft as it seeks to expand overseas.
  • Tencent owns approx. 5.0% of Ubisoft which was acquired in 2018 and is said to have reached out to the founding family Guillemot to buy a stake from their ownership.
  • As we mentioned in our previous insight, Tencent has been excluded for the fourth time from new game approvals which had impacted its online games biz.

Zhangzhou Pientzehuang Pharmaceutical (600436CH) 22H1- 2022 Is Stressful but Shares Will Bounce Back

By Xinyao (Criss) Wang

  • Due to the lockdown/pandemic, Pientzehuang Pharmaceutical’s 2022H1 performance slowed down. Considering the economic downturn and people’s cutting back spending on non-rigid consumption, the full-year revenue growth could be around 10%-20%.
  • The Company’s key challenge lies in revenue growth. However, it is not easy to increase sales largely due to the scarcity of raw materials, which limits the expansion of production.
  • Pien Tze Huang is overvalued. Share price could continue to fall,but it will bounce back due to its high moat. 2022 is a good time for bottom fishing this stock.

Morning Views Asia: China SCE, KWG Living Group, Longfor Properties, Sino-Ocean Service

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars